The global oral thin films market to register a CAGR of 13.7% between 2019 and 2026.
The report analyzes and forecasts the oral thin films market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2019 to 2026. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level. For the region and all segments, the sales, revenue and their market share, growth rate are key research objects; we can research the manufacturers' sales, price, revenue, cost and gross profit and their changes. What's more, we will display the main consumers, raw material manufacturers, distributors, etc.
This report first introduces the background of oral thin films, including the definition, classification, application, industrial chain structure, industry overview, national policy and planning analysis of the industry, and the latest dynamic analysis. With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major oral thin films companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of oral thin films upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of oral thin films and consumption, major regions and consumption, major global producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global oral thin films market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the oral thin films market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of oral thin films market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Companies Mentioned in Report
The report also profiles major players in the global oral thin films market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players in the global oral thin films market are ZIM Laboratories Limited, Indivior plc, Aquestive Therapeutics, Inc., Sumitomo Dainippon Pharma Co., Ltd., IntelGenx Corp., Pfizer, Inc., Novartis AG, Allergan plc, NAL Pharma, and Solvay
The global oral thin films market has been segmented as given below:
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.
Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
The study objectives of this report are:
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology
3. Executive Summary
3.1. Global Oral Thin Films Market Size (US$ Mn) and Distribution, by Region, 2018 and 2026
3.2. Global Oral Thin Films Market: Market Snapshot
4. Market Overview
4.1. Global Oral Thin Films Market: Product Overview
4.2. Global Oral Thin Films Market: Key Industry Developments
5. Market Dynamics
5.1. Drivers and Restraints Snapshot Analysis
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Global Oral Thin Films Market Revenue Projections (US$ Mn), 2016–2026
5.6. Porter’s Five Forces Analysis
5.7. Value Chain Analysis
5.8. Pipeline Analysis - Oral Thin Films Market
5.9. Global Oral Thin Films Market Outlook
6. Global Oral Thin Films Market Analysis, by Product
6.1. Introduction
6.2. Key Insights
6.3. Global Oral Thin Films Market Size and Forecast, by Product
6.3.1. Sublingual Film
6.3.2. Fast Dissolving Dental/Buccal Film
6.4. Global Oral Thin Films Market Analysis, by Product
6.5. Global Oral Thin Films Market Attractiveness Analysis, by Product
7. Global Oral Thin Films Market Analysis, by Disease Indication
7.1. Introduction
7.2. Key Insights
7.3. Global Oral Thin Films Market Size and Forecast, by Disease Indication
7.3.1. Schizophrenia
7.3.2. Migraine
7.3.3. Opioid Dependence
7.3.4. Nausea & Vomiting
7.3.5. Others
7.4. Global Oral Thin Films Market Analysis, by Disease Indication
7.5. Global Oral Thin Films Market Attractiveness Analysis, by Disease Indication
8. Global Oral Thin Films Market Analysis, by Distribution Channel
8.1. Introduction
8.2. Key Insights
8.3. Global Oral Thin Films Market Size and Forecast, by Distribution Channel
8.3.1. Hospital Pharmacies
8.3.2. Drug Store
8.3.3. Retail Pharmacies
8.3.4. E-Commerce
8.4. Global Oral Thin Films Market Analysis, by Distribution Channel
8.5. Global Oral Thin Films Market Attractiveness Analysis, by Distribution Channel
9. Global Oral Thin Films Market Analysis, by Region
9.1. Introduction
9.2. Key Insights
9.3. Global Oral Thin Films Market Size and Forecast , by Region, 2016–2026
9.3.1. North America
9.3.2. Europe
9.3.3. Asia Pacific
9.3.4. Latin America
9.3.5. Middle East & Africa
9.4. Global Oral Thin Films Market Analysis, by Region
9.5. Global Oral Thin Films Market Attractiveness Analysis, by Region
10. North America Oral Thin Films Market Analysis
10.1. North America Oral Thin Films Market Key Findings
10.2. North America Oral Thin Films Market Overview
10.3. North America Oral Thin Films Market Size and Forecast, by Product
10.3.1. Sublingual Film
10.3.2. Fast Dissolving Dental/Buccal Film
10.4. North America Oral Thin Films Market Size and Forecast, by Disease Indication
10.4.1. Schizophrenia
10.4.2. Migraine
10.4.3. Opioid Dependence
10.4.4. Nausea & Vomiting
10.4.5. Others
10.5. North America Oral Thin Films Market Size and Forecast, by Distribution Channel
10.5.1. Hospital Pharmacies
10.5.2. Drug Store
10.5.3. Retail Pharmacies
10.5.4. E-Commerce
10.6. North America Oral Thin Films Market Forecast, by Country
10.6.1. U.S.
10.6.2. Canada
10.7. North America Oral Thin Films Market Attractiveness Analysis
10.7.1. By Product
10.7.2. By Disease Indication
10.7.3. By Distribution Channel
10.7.4. By Country
11. Europe Oral Thin Films Market Analysis
11.1. Europe Oral Thin Films Market Key Findings
11.2. Europe Oral Thin Films Market Overview
11.3. Europe Oral Thin Films Market Size and Forecast, by Product
11.3.1. Sublingual Film
11.3.2. Fast Dissolving Dental/Buccal Film
11.4. Europe Oral Thin Films Market Size and Forecast, by Disease Indication
11.4.1. Schizophrenia
11.4.2. Migraine
11.4.3. Opioid Dependence
11.4.4. Nausea & Vomiting
11.4.5. Others
11.5. Europe Oral Thin Films Market Size and Forecast, by Distribution Channel
11.5.1. Hospital Pharmacies
11.5.2. Drug Store
11.5.3. Retail Pharmacies
11.5.4. E-Commerce
11.6. Europe Oral Thin Films Market Forecast, by Country/Sub-region
11.6.1. U.K.
11.6.2. France
11.6.3. Germany
11.6.4. Spain
11.6.5. Italy
11.6.6. Russia
11.6.7. Rest of Europe
11.7. Europe Oral Thin Films Market Attractiveness Analysis
11.7.1. By Product
11.7.2. By Disease Indication
11.7.3. By Distribution Channel
11.7.4. By Country/Sub-region
12. Asia Pacific Oral Thin Films Market Analysis
12.1. Asia Pacific Oral Thin Films Market Key Findings
12.2. Asia Pacific Oral Thin Films Market Overview
12.3. Asia Pacific Oral Thin Films Market Size and Forecast, by Product
12.3.1. Sublingual Film
12.3.2. Fast Dissolving Dental/Buccal Film
12.4. Asia Pacific Oral Thin Films Market Size and Forecast, by Disease Indication
12.4.1. Schizophrenia
12.4.2. Migraine
12.4.3. Opioid Dependence
12.4.4. Nausea & Vomiting
12.4.5. Others
12.5. Asia Pacific Oral Thin Films Market Size and Forecast, by Distribution Channel
12.5.1. Hospital Pharmacies
12.5.2. Drug Store
12.5.3. Retail Pharmacies
12.5.4. E-Commerce
12.6. Asia Pacific Oral Thin Films Market Forecast, by Country/Sub-region
12.6.1. Japan
12.6.2. India
12.6.3. China
12.6.4. Rest of Asia Pacific
12.7. Asia Pacific Oral Thin Films Market Attractiveness Analysis
12.7.1. By Product
12.7.2. By Disease Indication
12.7.3. By Distribution Channel
12.7.4. By Country/Sub-region
13. Latin America Oral Thin Films Market Analysis
13.1. Latin America Oral Thin Films Market Key Findings
13.2. Latin America Oral Thin Films Market Overview
13.3. Latin America Oral Thin Films Market Size and Forecast, by Product
13.3.1. Sublingual Film
13.3.2. Fast Dissolving Dental/Buccal Film
13.4. Latin America Oral Thin Films Market Size and Forecast, by Disease Indication
13.4.1. Schizophrenia
13.4.2. Migraine
13.4.3. Opioid Dependence
13.4.4. Nausea & Vomiting
13.4.5. Others
13.5. Latin America Oral Thin Films Market Size and Forecast, by Distribution Channel
13.5.1. Hospital Pharmacies
13.5.2. Drug Store
13.5.3. Retail Pharmacies
13.5.4. E-Commerce
13.6. Latin America Oral Thin Films Market Forecast, by Country/Sub-region
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Latin America Oral Thin Films Market Attractiveness Analysis
13.7.1. By Product
13.7.2. By Disease Indication
13.7.3. By Distribution Channel
13.7.4. By Country/Sub-region
14. Middle East & Africa Oral Thin Films Market Analysis
14.1. Middle East & Africa Oral Thin Films Market Key Findings
14.2. Middle East & Africa Oral Thin Films Market Overview
14.3. Middle East & Africa Oral Thin Films Market Size and Forecast, by Product
14.3.1. Sublingual Film
14.3.2. Fast Dissolving Dental/Buccal Film
14.4. Middle East & Africa Oral Thin Films Market Size and Forecast, by Disease Indication
14.4.1. Schizophrenia
14.4.2. Migraine
14.4.3. Opioid Dependence
14.4.4. Nausea & Vomiting
14.4.5. Others
14.5. Middle East & Africa Oral Thin Films Market Size and Forecast, by Distribution Channel
14.5.1. Hospital Pharmacies
14.5.2. Drug Store
14.5.3. Retail Pharmacies
14.5.4. E-Commerce
14.6. Middle East & Africa Oral Thin Films Market Forecast, by Country/Sub-region
14.6.1. South Africa
14.6.2. Saudi Arabia
14.6.3. UAE
14.6.4. Rest of Middle East & Africa
14.7. Middle East & Africa Oral Thin Films Market Attractiveness Analysis
14.7.1. By Product
14.7.2. Disease Indication
14.7.3. By Distribution Channel
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Global Oral Thin Films Market Share Analysis, by Company (2016)
15.2. Company Profiles
15.2.1. ZIM Laboratories Limited
15.2.1.1. Overview (HQ, Employee Strength, Business Segments)
15.2.1.2. Financials
15.2.1.3. Recent Developments
15.2.1.4. Strategy
15.2.2. Indivior plc
15.2.2.1. Overview (HQ, Employee Strength, Business Segments)
15.2.2.2. Financials
15.2.2.3. Recent Developments
15.2.2.4. Strategy
15.2.3. Aquestive Therapeutics, Inc.
15.2.3.1. Overview (HQ, Employee Strength, Business Segments)
15.2.3.2. Financials
15.2.3.3. Recent Developments
15.2.3.4. Strategy
15.2.4. Sumitomo Dainippon Pharma Co., Ltd.
15.2.4.1. Overview (HQ, Employee Strength, Business Segments)
15.2.4.2. Financials
15.2.4.3. Recent Developments
15.2.4.4. Strategy
15.2.5. IntelGenx Corp.
15.2.5.1. Overview (HQ, Employee Strength, Business Segments)
15.2.5.2. Financials
15.2.5.3. Recent Developments
15.2.5.4. Strategy
15.2.6. Pfizer, Inc.
15.2.6.1. Overview (HQ, Employee Strength, Business Segments)
15.2.6.2. Financials
15.2.6.3. Recent Developments
15.2.6.4. Strategy
15.2.7. Novartis AG
15.2.7.1. Overview (HQ, Employee Strength, Business Segments)
15.2.7.2. Financials
15.2.7.3. Recent Developments
15.2.7.4. Strategy
15.2.8. Allergan plc
15.2.8.1. Overview (HQ, Employee Strength, Business Segments)
15.2.8.2. Financials
15.2.8.3. Recent Developments
15.2.8.4. Strategy
15.2.9. NAL Pharma
15.2.9.1. Overview (HQ, Employee Strength, Business Segments)
15.2.9.2. Financials
15.2.9.3. Recent Developments
15.2.9.4. Strategy
15.2.10. Solvay
15.2.10.1. Overview (HQ, Employee Strength, Business Segments)
15.2.10.2. Financials
15.2.10.3. Recent Developments
15.2.10.4. Strategy
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers